ASRS
INO icon

Arizona State Retirement System’s Inovio Pharmaceuticals INO Stock Holding History

Arizona State Retirement System’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,024
Closed -$59.3K – 2207
2023
Q1 		$59.3K Buy
6,024
+159
+3% +$2.71K ﹤0.01% 2174
2022
Q4 		$110K Buy
5,865
+678
+13% +$15.4K ﹤0.01% 2090
2022
Q3 		$107K Buy
5,187
+436
+9% +$11.2K ﹤0.01% 2075
2022
Q2 		$99K Buy
4,751
+12
+0.3% +$338 ﹤0.01% 2117
2022
Q1 		$204K Buy
4,739
+21
+0.4% +$946 ﹤0.01% 2003
2021
Q4 		$283K Sell
4,718
-10
-0.2% -$801 ﹤0.01% 1866
2021
Q3 		$406K Buy
4,728
+45
+1% +$4.52K ﹤0.01% 1662
2021
Q2 		$521K Sell
4,683
-332
-7% -$31.9K ﹤0.01% 1547
2021
Q1 		$559K Buy
5,015
+967
+24% +$127K ﹤0.01% 1482
2020
Q4 		$430K Buy
4,048
+73
+2% +$9.72K ﹤0.01% 1540
2020
Q3 		$553K Buy
3,975
+1,230
+45% +$256K 0.01% 1247
2020
Q2 		$888K Buy
+2,745
New +$441K 0.01% 811

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arizona State Retirement System's INO Position: Q2 2023 in Review

Arizona State Retirement System sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 6,024 shares — an estimated $59.3K sold.

Arizona State Retirement System first reported a position in INO in Q2 2020 and held it in 12 quarters. The position peaked at $888K in Q2 2020. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

  • Arizona State Retirement System reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 6,024 Inovio Pharmaceuticals shares in Q2 2023, an estimated $59.3K.
  • Arizona State Retirement System first reported a position in Inovio Pharmaceuticals in Q2 2020 and held it in 12 quarters.
  • Arizona State Retirement System's Inovio Pharmaceuticals position peaked at $888K in Q2 2020.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.